Bio-Path (BPTH) to Release Quarterly Earnings on Friday

Bio-Path (NASDAQ:BPTH) will be announcing its earnings results before the market opens on Friday, November 15th. Analysts expect the company to announce earnings of ($1.02) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Bio-Path (NASDAQ:BPTH) last released its earnings results on Thursday, August 15th. The company reported ($1.16) earnings per share for the quarter, topping the consensus estimate of ($1.54) by $0.38. During the same quarter in the previous year, the company posted ($10.60) EPS. On average, analysts expect Bio-Path to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Bio-Path Trading Up 1.6 %

NASDAQ:BPTH opened at $0.88 on Thursday. Bio-Path has a 12 month low of $0.80 and a 12 month high of $12.40. The firm has a fifty day simple moving average of $0.99 and a 200-day simple moving average of $1.61.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Bio-Path in a research report on Friday, November 8th. They set a “sell” rating for the company.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.